Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Concord Medical to IPO Next Week on NYSE

publication date: Dec 4, 2009
Concord Medical Services Holdings Ltd., a company that operates radiation therapy and diagnostic imaging centers in China, plans to raise $126 million its IPO on December 10. The company claims to be the largest provider of radiotherapy and diagnostic imaging services in China. It currently operates 83 centers in 55 hospitals, located in 36 cities across China. In the first nine months of 2009, Concord produced $30 million of revenue and $13 million of net income. At $11 per share, Concord would have a market capitalization of $516 million. More details...

Stock Symbol: (NYSE: CCM)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital